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Abstract 
Herein, we used protein semisynthesis to investigate, for the first time, the effect of lysine acetylation 
and phosphorylation, as well as the crosstalk between these modifications on the structure and 
aggregation of mutant huntingtin exon1 (Httex1). Our results demonstrate that phosphorylation at T3 
stabilizes the α-helical conformation of the N-terminal 17 amino acids (Nt17) and significantly inhibits 
the aggregation of mutant Httex1. Acetylation of single lysine residues, K6, K9 or K15, had no effect 
on Httex1 aggregation. Interestingly, acetylation at K6, but not at K9 or K15, reversed the inhibitory 
effect of T3 phosphorylation. Together, our results provide novel insight into the role of Nt17 post-
translational modifications in regulating the structure and aggregation of Httex1 and suggest that its 
aggregation and possibly its function(s) are controlled by regulatory mechanisms involving crosstalk 
between different PTMs. 
Main text 
Several lines of evidence suggest that the first N-terminal 17 amino acids of the Huntingtin protein 
(Htt) play important roles in modulating Htt structure, oligomerization, fibrils formation, membrane 
binding, subcellular localization and interactions with other proteins.[1] This, combined with the fact 
that this short N-terminal sequence harbors several residues that are subjected to diverse post-
translational modifications (PTMs), including phosphorylation, acetylation, ubiquitination and 
sumoylation (Scheme S1-A in the Supporting Information), suggests that PTMs may serve as reversible 
molecular switches for regulating Htt structure, interactome, cellular properties and toxicity.[2] 
However, the lack of knowledge about the enzymes involved in regulating these modifications has 
made it difficult to decipher their role in regulating the function(s) of Htt in health and disease. 
To address these limitations and enable deciphering of the Nt17 PTM code, our group has pursued 
the development of semisynthetic strategies that permit site-specific introduction of single or multiple 
PTMs within Nt17 of Huntingtin exon 1 (Httex1). Recently, we reported a semisynthetic strategy that 
permits site-specific phosphorylation at T3.[3] However, this strategy suffered from several limitations 
and was only suitable for introducing PTMs in the first N-terminal 9 residues of wild-type Httex1 (≤23 
glutamine residues) (Scheme S2).[3] To allow investigations of all Nt17 PTMs, we developed and 
optimized two new modular semisynthetic protocols that permit the generation of wild-type and for 
the first time mutant Httex1 (mHttex1) proteins containing single or multiple PTMs (Scheme S3). The 
first strategy (Scheme S3-A) is only suitable for introducing PTMs in the N-terminal 9 residues of 
Httex1, whereas the second strategy allows the investigation of all the PTMs within the Nt17 domain. 
Additionally, the optimized conditions enabled the semisynthesis of mutant Httex1 (full details about 
these semisynthetic strategies are given in the Supporting Information). This optimized strategy 
enabled us, for the first time, to generate milligram quantities of mHttex1 (43Q) phosphorylated at T3 
(pT3) or acetylated at K6, K9 or K15 (AcK6, AcK9, AcK15), as well as Httex1 containing multiple 
combination of both PTMs (pT3/AcK6, pT3/AcK9, pT3/AcK15) to probe the potential of cross-talk 
between these modifications. 
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Threonine 3 (T3) has been identified as one of the most common phosphorylation sites in Htt from 
ST14A and HeLa cells and was detected at lower levels in the post-mortem brain regions most affected 
by HD in a mouse model of HD (CAG140).[4, 5] Interestingly, the level of T3 phosphorylation was 
inversely correlated with polyQ repeat length, suggesting that phosphorylation at T3 is decreased in 
pathological conditions and that restoring the physiological level of T3 phosphorylation might 
ameliorate HD pathology.[4] Testing this hypothesis has not been possible because the enzymes 
involved in regulating T3 phosphorylation remain elusive and the extent to which phosphomimetic 
mutations can reproduce the effect of phosphorylation remains unknown. 
To address this knowledge gap, we sought to 1) determine the effect of T3 phosphorylation on 
mHttex1 aggregation and 2) to determine whether the phosphomimetic mutation (T3D/E), which is 
commonly used to assess T3 phosphorylation in cellular and animal models of HD, reproduces the 
effects of authentic T3 phosphorylation on the structure and aggregation of mutant Httex1. To achieve 
these goals, we prepared pT3 and T3D mHttex1-43Q using the new semisynthetic strategy (Figure S6). 
Sedimentation analysis of the unmodified mHttex1-43Q showed that circa 75 % of the protein 
aggregated within 12 h at 37 °C and that nearly complete depletion of the soluble protein fraction 
occurred between 24 and 36 h (Figure 1 A). This was accompanied by a shift in the circular dichroism 
(CD) spectrum that is indicative of a change in secondary structure from a predominantly disordered 
structure (λmin 205 nm) to a β-sheet-rich structure (λmin 215 nm, Figure 1 B), consistent with the 
observation of fibrillar aggregates at 48 h by transmission electron microscopy (TEM) (Figure S7 and 
S8). In contrast, 89 % and >60 % mHttex1-pT3 remained soluble after 12 and 48 h of incubation, 
respectively (Figure 1 A). No major change in the secondary structure of Httex1-pT3 was observed by 
CD even after 48 h (Figure 1 B). TEM analysis showed mainly oligomers and short fibrillar structures 
with shorter average lengths than those formed by unmodified mHttex1 (Figure S7 and S8). Similar 
inhibitory effects were observed at higher protein concentrations. Fibrils formation by mHttex1-pT3 
was only observed at concentrations of ≥30 μm (Figure S9). Interestingly, the strong β-sheet and 
aggregation inhibitory effect induced by phosphorylation at T3 were not fully reproduced by the 
phosphomimetic mutation (T3D) (Figure 1). The fibrils formed by mHttex1-T3D were of intermediate 
size (Figure S7) compared to those formed by pT3 and unmodified mHttex1 (Figure S7 and S8). 
Detailed characterization of the morphology and dimensions of the aggregates formed by pT3 and 
T3D by high-resolution atomic force microscopy (AFM) are presented in Figure S10. After 48 h of 
incubation, unmodified mHttex1 formed mature fibrillar species (Figure 1 C) with an average length 
of 189±103 nm and height of 6±1 nm (Figure 1 D). The mHttex1-T3D exhibited shorter fibrils (106±49 
nm) with average heights of 5.5±0.5 nm. In the case of mHttex1-pT3, mainly protofibril-like structures 
with average lengths and heights of 71±30 nm and 4.6±0.5 nm were observed (Figure 1 D). These 
observations suggest that the phosphomimetic mutation reproduces only partially the effect of 
phosphorylation at T3. 
To gain insight into the mechanism by which this modification inhibits mutant Httex1 aggregation, we 
investigated the effects of phosphorylation and phosphomimetics at T3 on the structure of Nt17 
peptides. Htt1-19 showed a CD spectrum indicative of a mainly random coil structure mixed with 
partially α-helical structures consistent with previous CD and atomistic simulation studies (Figure 
2 A).[6, 7] In contrast, the CD spectrum of Htt1-19-pT3 showed a double minimum at 208 and 222 nm, 
indicative of a predominantly α-helical structure (Figure 2 A). To the best of our knowledge, this is the 
most striking stabilization of Nt17 helical conformation without the use of fluorinated solvents (e.g. 
TFE). The pT3-induced α-helical structure is pH-sensitive. N-terminal acetylation increases the pT3-
induced helicity, but the overall helicity follows the same linear decrease with decreasing pH in the 
presence or absence of acetylation (Figure 2 B). The HttAc2-19 T3E and T3D peptides exhibited CD 
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spectra similar to that of the unmodified HttAc2-19 peptide (Figure 2 A), confirming again that these 
mutations do not reproduce the effects of phosphorylation at T3 on the structural properties of Nt17. 
Next, we conducted nuclear magnetic resonance (NMR) studies of the conformation of Htt1-19 and 
Htt1-19pT3 (Table S2) in aqueous buffer and in 2,2,2-trifluoroethanol (TFE) (33 %) and compared their 
chemical shifts and the NOESY patterns.[8] The spectra of Htt1-19 and Htt1-19pT3 have similar 
features in aqueous buffer and TFE with similar chemical shifts for residues 6–19. However, the amide 
proton of T3 appears significantly shifted in Htt1-19 pT3, which is highly shifted downfield at 
approximatively 9.9 ppm (>1.5 ppm) compared to the unmodified peptide (Figure 2 C,D, left). 
Phosphorylated peptides do not typically present such a chemical shift variation. Even more notable 
is the NOE pattern. In buffer (Figure 2 C,D, right), the spectrum of Htt1-19 has clear features of a 
nascent helix (HN-HN connectivity) that can be stabilized by fluoroalcohols (TFE) demonstrating a 
propensity to assume a stable α-helical conformation. The NOESY spectra of Htt1-19 in TFE (Figure 
2 E) show uninterrupted sequential HN–HN connectivities and other NOE patterns expected for helical 
structures (HNi–HNi+1, Hαi–HNi+4 and Hαi–HNi+4) in the tract 5–19. Residues M1, A2 and T3 are not 
identifiable indicating a high flexibility of the N-terminus where the helix frays. In the NOESY of Htt1-
19pT3, the resonance of the T3 amide of Htt1-19pT3 forms unmistakable sequential HN-HN 
connectivities with the previous and following amide groups, indicating that the phosphorylated T3 
residue is strongly rigidified compared to the unmodified residue extending α-helix structure to A2. 
Although acetylation of lysine residues within Nt17 has been proposed to play a role in regulating its 
association with membranes,[9] only K9 was reported to be acetylated in HEK cells[10] and was 
proposed to play an important role in Htt clearance.[11] Chaibva et al. reported that acetylation of 
Httex1 retards fibrils formation in vitro.[9] However, it is noteworthy that their findings were based 
on nonselective chemical acetylation of all lysine residues in a model peptide of Httex1 lacking the last 
39 C-terminal residues and containing two non-native lysines residues which were also partially 
acetylated. To investigate the effect of lysine acetylation on Httex1 aggregation, we produced both 
WT (23Q) and mutant (43Q) Httex1 acetylated at single lysine residues (AcK6, AcK9, and AcK15). Figure 
3 demonstrates that acetylation at single lysine residues does not significantly influence the 
aggregation of WT or mutant Httex1 (Figure 3, Figure S8 and S11), except for acetylation at K6 that 
appeared to slightly delay mHttex1 aggregation. Although we observed a trend of a slightly 
accelerated aggregation of Httex1 acetylated at K9 and K15, the differences in aggregation kinetics 
compared to the unmodified Httex1 were not statistically significant. In all cases, the loss of soluble 
protein was accompanied by a shift in the secondary structure from random coil to β-sheet structure 
(Figure 3 B) and by the formation of fibrillar aggregates of comparable morphology and length (Figure 
3 C, Figure S8). These findings suggest that lysine acetylation at K6, K9 or K15 alone does not play a 
critical role in the regulation of Httex1 aggregation in vitro. 
Given the close proximity of lysine residues K6, K9 and K15 to neighboring phosphorylation sites (T3, 
S13 and S16), we examined the potential crosstalk between lysine acetylation and phosphorylation 
within Nt17. We focused initially on phosphorylation at T3 and acetylation at K6 because of the close 
proximity of the two residues, also due to the role of K6 in stabilizing pT3-induced Nt17 helix formation 
and the striking inhibitory effect of pT3 on mHttex1 aggregation. Sedimentation analysis showed that 
mHttex1-pT3/AcK6 exhibited similar aggregation profile as unmodified mHttex1 and mHttex1-AcK6 
(Figure 3 A), whereas mHttex1-pT3/AcK9 and mHttex1- pT3/AcK15 Q18A, exhibited similar 
aggregation profiles as mHttex1-pT3. These findings indicate that K6, but not K9 or K15 acetylation 
reverses the inhibitory effect of T3 phosphorylation on mutant Httex1 aggregation. Consistent with 
this hypothesis, only mHttex1-pT3/AcK6 converted to β-sheet-rich fibrillar structures after 48 h of 
incubation, whereas mutant mHttex1-pT3, mHttex1-pT3/AcK9 or mHttex1-pT3/AcK15 exhibited CD 
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spectra consistent with a predominantly disordered conformation (Figure 3 B,C and S12). mHttex1-
pT3/AcK6 and mHttex1-AcK6 formed predominantly long mature fibrils of similar size (height >6 nm, 
length 50–350 nm), whereas mHttex1-pT3 formed predominantly short protofibrillar species (height 
<5 nm, length 50–150 nm) (Figure S13). Similar observations were made at higher protein 
concentrations (30–45 μm, Figure S14). To determine if the effect of acetylation at K6 on the 
aggregation inhibitory effects of phosphorylation at T3, we investigated by NMR the role of K6 in 
stabilizing/destabilizing the N-terminal helical conformation induced by pT3. We compared the 
behavior of the N-terminally protected phosphorylated and non-phosphorylated AcHtt2-17AcK6 
peptides, where K6 was neutralized with acetylation, to that of AcHtt2-17. As it has become clear to 
us that native Htt is N-terminally acetylated, all the peptides used to investigate the interplay between 
T3 phosphorylation and K6 acetylation were N-terminally acetylated. As shown in Figure 2 A, N-
terminal acetylation does not significantly alter the conformational properties of Nt17. Both AcHtt2-
17pT3 and AcHtt2-17pT3/AcK6 present the resonance of pT3 down-field shifted as compared to 
AcHtt2-17 and AcHtt2-17AcK6 (Figure S15). However, the NOESY pattern of AcHtt2-17pT3 and AcHtt2-
17pT3/AcK6 are similar, indicating that acetylation at K6 does not significantly alter the Nt17 helical 
conformation (Figure S15). Our NMR results are confirmed by the CD analysis of the same peptides, 
which showed that pT3 and pT3/AcK6 Httex1 exhibit similar helical structure and contents (Figure 
S16). These findings are consistent with emerging evidence that the role of the Nt17 in regulating 
Httex1 aggregation is determined by factors that influence not only the conformation of this peptide 
but also its interactions with itself and the polyQ domain.[6, 12, 13] The existing data do not support 
a direct and simple relationship between Nt17 helicity and Httex1 aggregation, suggesting that Httex1 
aggregation can proceed through distinct amyloidogenic conformations. Therefore, more studies are 
needed to dissect the different mechanisms by which PTMs or crosstalk between PTMs influence the 
intra- and intermolecular interactions of Httex1, the amyloidogenic conformation of the polyQ domain 
and Httex1 aggregation. 
 
We have described herein the first semisynthesis of mutant Httex1 (43Q). Our improved method 
allows the production of milligram quantities of mutant Httex1 and enables the homogeneous Httex1 
preparations with site-specifically modifications at single or multiple residues. This enabled us for the 
first time, to perform detailed studies comparing the effects of phosphorylation at T3 and acetylation 
at K6, K9 or K15 and assessing the crosstalk between the two modifications (pT3/AcK6, pT3/AcK9 and 
pT3/AcK15) on the Httex1 aggregation. Our results demonstrated that acetylation of single lysine 
residues within the N-terminal 17 amino acids of Httex1 did not significantly modify the aggregation 
kinetics or structural properties of wild-type or mutant Httex1. In contrast, phosphorylation at T3 
resulted in dramatic stabilization of Nt17 helical conformation and inhibition of mutant Httex1 
aggregation. In contrast the The phosphomimetic T3D mutation had no effect on Nt17 conformation 
and resulted in only intermediate inhibition of Httex1, demonstrating that this mutation does not 
reproduce the structural and aggregation properties of authentic phosphorylation. Finally, we showed 
that K6, but not K9 or K15 acetylation reverses the inhibitory effect of T3 phosphorylation on Httex1 
aggregation. Our results suggest that phosphorylation/dephosphorylation of T3 and/or the crosstalk 
between T3 phosphorylation and acetylation represent PTM-dependent molecular switches for 






This work was supported by the CHDI foundation (A_7627) and the Swiss National Science Foundation 
(31003A-146680). We thank Dr. Mahmood Haj-Yahya, Dr. John Warner, Dr. Elizabeth Doherty, Dr. 
Celia Dominguez and Dr. Andrea Caricasole for helpful discussions on the manuscript, and IRBM for 
generating the Nt17 peptides used in this study. We are grateful to Dr G. Kelly and Dr T. Frenkiel at 
the MRC Biomedical NMR Centre (The Francis Crick Institute) for providing access to the NMR facilities 
and help in acquiring spectra. 
Conflict of interest 
The authors declare no conflict of interest. 
References 
1 J. R. Arndt, M. Chaibva, J. Legleiter, Biomol. Concepts 2015, 6, 33–46. 
2 D. E. Ehrnhoefer, L. Sutton, M. R. Hayden, Neuroscientist 2011, 17, 475–492. 
3 A. Ansaloni, Z. M. Wang, J. S. Jeong, F. S. Ruggeri, G. Dietler, H. A. Lashuel, Angew. Chem. Int. Ed. 
2014, 53, 1928–1933; 
4 C. T. Aiken, J. S. Steffan, C. M. Guerrero, H. Khashwji, T. Lukacsovich, D. Simmons, J. M. Purcell, K. 
Menhaji, Y. Z. Zhu, K. Green, F. Laferla, L. Huang, L. M. Thompson, J. L. Marsh, J. Biol. Chem. 2009, 284, 
29427–29436. 
5 M. B. Bustamante, A. Ansaloni, J. F. Pedersen, L. Azzollini, C. Cariulo, Z. M. Wang, L. Petricca, M. 
Verani, F. Puglisi, H. Park, H. Lashuel, A. Caricasole, Biochem. Biophys. Res. Commun. 2015, 463, 1317–
1322. 
6 T. E. Williamson, A. Vitalis, S. L. Crick, R. V. Pappu, J. Mol. Biol. 2010, 396, 1295–1309. 
7 R. S. Atwal, C. R. Desmond, N. Caron, T. Maiuri, J. R. Xia, S. Sipione, R. Truant, Nat. Chem. Biol. 2011, 
7, 453–460. 
8 M. Buck, Q. Rev. Biophys. 1998, 31, 297–355. 
9 M. Chaibva, S. Jawahery, A. W. Pilkington, J. R. Arndt, O. Sarver, S. Valentine, S. Matysiak, J. Legleiter, 
Biophys. J. 2016, 111, 349–362. 
10 X. Cong, J. M. Held, F. DeGiacomo, A. Bonner, J. M. Chen, B. Schilling, G. A. Czerwieniec, B. W. 
Gibson, L. M. Ellerby, Mol. Cell. Proteomics 2011, 10, M111 009829. 
11 L. M. Thompson, C. T. Aiken, L. S. Kaltenbach, N. Agrawal, K. Illes, A. Khoshnan, M. Martinez-
Vincente, M. Arrasate, J. G. O'Rourke, H. Khashwji, T. Lukacsovich, Y. Z. Zhu, A. L. Lau, A. Massey, M. 
R. Hayden, S. O. Zeitlin, S. Finkbeiner, K. N. Green, F. M. LaFerla, G. Bates, L. Huang, P. H. Patterson, D. 
C. Lo, A. M. Cuervo, J. L. Marsh, J. S. Steffan, J. Cell Biol. 2009, 187, 1083–1099. 
12 S. L. Crick, K. M. Ruff, K. Garai, C. Frieden, R. V. Pappu, Proc. Natl. Acad. Sci. USA 2013, 110, 20075–
20080. 
13 S. Tam, C. Spiess, W. Auyeung, L. Joachimiak, B. Chen, M. A. Poirier, J. Frydman, Nat. Struct. Mol. 







Figure 1. Aggregation of mHttex1-pT3 and T3D compared to unmodified mHttex1 at 3 μm. A) 
Sedimentation assay (loss of soluble protein) based on RP-UPLC (n=6, fitted with exponential decay). 
B) CD analysis of the samples at 0 and 48 h. C) AFM characterization of unmodified mHttex1 and 
mHttex1-pT3 and T3D aggregates. The XY scale bars are 200 nm, the Z scales are in nm. D) Height and 





Figure 2. NMR and circular dichroism analysis of the Htt1-19 peptides. A) Far-UV CD spectra of WT and 
pT3 Htt1-19 peptides compared to WT, pT3, T3E and T3D HttAc2-19 at pH 7.0 in aqueous buffer. B) 
Helical content of each peptide as a function of pH. C and D) 1D WATERGATE and 2D homonuclear 
NOESY spectra of Htt1-19 phosphorylated in position 3 and non-phosphorylated, respectively. E and 
F) Same as in (C) and (D) in the presence of 33 % TFE: also reported is the assignment of the NH–NH 
chemical shifts typical of α-helical structure, a star highlights the characteristic signals arising upon 





Figure 3. Aggregation of single lysine acetylated mHttex1 and mHttex1 phosphorylated at T3 and 
acetylated at-AcK6, AcK9, or AcK15. A) Sedimentation assay (loss of soluble protein) based on RP-UPLC 
(n=6, fitted with exponential decay). B) CD analysis and C) TEM images of the proteins after 48 h of 
aggregation. D) Height and length quantification of the aggregates by AFM at 48 h. 
 
